Unspecified neprilysin inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Unspecified neprilysin inhibitor, covering 2026-02-25 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction [Phase 4]